Targeting the circulating microRNA signature of obesity

Clinical Chemistry

Volumn 59, Issue 5, 2013, Pages 781-792

  Ortega, Francisco José ^a,b   Mercader, Josep María ^c   Catalán, Victoria ^b,d   Moreno Navarrete, José María ^a,b   Pueyo, Neus ^a,b   Sabater, Mónica ^a   Gómez Ambrosi, Javier ^b,d   Anglada, Roger ^e   Fernández Formoso, José Antonio ^b   Ricart, Wifredo ^a,b   Frühbeck, Gema ^b,d   Fernández Real, José Manuel ^a,b  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR RECEPTOR; MICRORNA; MICRORNA 122; MICRORNA 125B; MICRORNA 126; MICRORNA 130B; MICRORNA 140-5P; MICRORNA 142-3P; MICRORNA 15A; MICRORNA 16-1; MICRORNA 193A-5P; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 423-5P; MICRORNA 483-5P; MICRORNA 520C-3P; MICRORNA 532-5P; MICRORNA 590-5P; MICRORNA 625; MICRORNA 636; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; FEMALE; HUMAN; MALE; MORBID OBESITY; WEIGHT REDUCTION;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHT; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OBESITY, MORBID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84876940768     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.195776     Document Type: Article

References (40)

1. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91. (Pubitemid 39025053)
2. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001;104:531-43. (Pubitemid 32201948)
3. Yang X, Jiao R, Yang L, Wu LP, Li YR, Wang J. New-generation high-throughput technologies based 'omics' research strategy in human disease (in Chinese). Yi Chuan 2011;33:829-46.
4. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008;27:5959-74.
5. Hernando E. MicroRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol 2007;9:155-60.
6. Perera RJ, Ray A. MicroRNAs in the search for understanding human diseases. BioDrugs 2007;21:97-104. (Pubitemid 46624554)
7. Ortega FJ, Moreno-Navarrete JM, Pardo G, Sabater M, Hummel M, Ferrer A, et al. miRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One 2010;5:e9022.
8. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008;105:10513-8.
9. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010;391:73-7.
10. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009;4:e7405.
11. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, et al. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009;55:1977-83.
12. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2011;107:810-7.
13. Ogawa R, Tanaka C, Sato M, Nagasaki H, Sugimura K, Okumura K, et al. Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun 2010;398:723-9.
14. Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2012;93:555-62.
15. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2012;13:423-33.
16. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, et al. Toward the blood-borne miRNome of human diseases. Nat Methods 2011;8:841-3.
17. Moreno-Navarrete JM, Martinez-Barricarte R, Catalan V, Sabater M, Gomez-Ambrosi J, Ortega FJ, et al. Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes 2010;59:200-9.
18. Catalan V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, Rotellar F, Valenti V, et al. Increased circulating and visceral adipose tissue expression levels of Ykl-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass. J Clin Endocrinol Metab 2011;96:200-9.
19. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, Vandesompele J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009;10:R64.
20. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
21. Chang J, Wittert G. Effects of bariatric surgery on morbidity and mortality in severe obesity. Int J Evid Based Healthc 2009;7:43-8.
22. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741-52. (Pubitemid 47295641)
23. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577-85.
24. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 2009;25:1991-3.
25. Sun W, Shen W, Yang S, Hu F, Li H, Zhu TH. MiR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-beta. Cell Res 2010;20:1158-69.
26. Joyce CE, Zhou X, Xia J, Ryan C, Thrash B, Menter A, et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet 2011;20:4025-40.
27. Makino K, Jinnin M, Kajihara I, Honda N, Sakai K, Masuguchi S, et al. Circulating miR-142-3p levels in patients with systemic sclerosis. Clin Exp Dermatol 2012;37:34-9.
28. Nicolas FE, Pais H, Schwach F, Lindow M, Kauppinen S, Moulton V, Dalmay T. Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA 2008;14:2513-20.
29. Kim D, Song J, Kim S, Kang SS, Jin EJ. MicroRNA-142-3p regulates TGF-beta3-mediated regiondependent chondrogenesis by regulating ADAM9. Biochem Biophys Res Commun 2011;414:653-9.
30. Fujita T, Teramoto K, Ozaki Y, Hanaoka J, Tezuka N, Itoh Y, et al. Inhibition of transforming growth factor-beta-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types. Cancer Res 2009;69:5142-50.
31. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 2010;70:2789-98.
32. Zamani N, Brown CW. Emerging roles for the transforming growth factor-beta superfamily in regulating adiposity and energy expenditure. Endocr Rev 2011;32:387-403.
33. Aubert J, Dessolin S, Belmonte N, Li M, McKenzie FR, Staccini L, et al. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J Biol Chem 1999;274:24965-72.
34. Ren J, Jin P, Wang E, Marincola FM, Stroncek DF. MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med 2009;7:20.
35. Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Sacca M, Memeo L, et al. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene 2011;30:4231-42.
36. Gomez-Ambrosi J, Catalan V, Rodriguez A, Ramirez B, Silva C, Gil MJ, et al. Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. J Nutr Biochem 2010;21:774-80.
37. Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. Microrna-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract 2011;91:94-100.
38. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 2011;47:784-91.
39. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM. miR423-5p as a circulating biomarker for heart failure. Circ Res 2010;106:1035-9.
40. Aoki N, Jin-no S, Nakagawa Y, Asai N, Arakawa E, Tamura N, et al. Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology 2007;148:3850-62. (Pubitemid 47105834)